Air sanitization for indoor spaces, so life never stops.
We are AeroClean™
AeroClean is a pathogen elimination technology company on a mission to keep work, play and life going—with continuous air sanitization products called, Pūrgo™ (pure-go.) We create solutions for hospitals, offices and many shared spaces as well as elevators, travel and more.
Pūrgo™ products feature SteriDuct™, proprietary technology developed by our best-in-class aerospace engineers, medical scientists and innovators. Powered by SteriDuct™, our solutions are medical grade, destroying 99.99% of viral, fungal and bacterial airborne pathogens.
Our purpose is simple; to never stop innovating solutions that keep people healthy and safe, so life never stops.
AeroClean was established in 2015 by co-founders, Amin J. Khoury, PhD, David Helfet, M.D, and Mark Krosney, to fulfill their mission to provide solutions for the critical challenges posed by harmful airborne pathogens and resultant hospital-acquired infections (“HAIs”). It is estimated that there are approximately 2 million HAIs acquired in outpatient treatment facilities annually in the United States, causing approximately 100,000 deaths and costing over $30 billion. Many HAIs are caused by the presence of harmful airborne pathogens.
The onset of COVID-19 has increased our urgency to create innovative and more effective air purification and sanitization solutions for the risks posed by harmful airborne pathogens, including coronavirus and other viruses, bacteria, molds, particles, fungi and allergens. Studies have shown 85% of COVID-19 transmission to be airborne person-to-person in the form of aerosolized droplets and in enclosed spaces. The Journal of Science estimates the annual U.S. cost of flu and respiratory infections at $50 billion, and the World Health Organization estimates that 4 million premature deaths annually are caused by air pollution.
The genesis of our proprietary air purification technology traces back to efforts to address commercial aircraft cabin air quality. Mr. Krosney is a highly accomplished scientist who is primarily responsible for numerous patents, several of which are important components of our IP portfolio. Dr. Khoury, the founder, and long-time Chairman and Chief Executive Officer of B/E Aerospace, envisioned the significant potential to apply such proprietary technology for revolutionary, medical-grade air purification solutions for hospitals and other critical healthcare settings. Dr. Khoury consulted with Dr. David Helfet, a leading orthopedic surgeon at both the Hospital for Special Surgery and New York-Presbyterian Hospital, regarding possible solutions for the critical challenges to patients and hospitals posed by harmful airborne pathogens and HAIs. This collaboration has served as the foundation for our Company and the implementation of our air sanitization solutions.